摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Isobutyl-2,5-diazabicyclo[2.2.1]heptane

中文名称
——
中文别名
——
英文名称
2-Isobutyl-2,5-diazabicyclo[2.2.1]heptane
英文别名
2-(2-methylpropyl)-2,5-diazabicyclo[2.2.1]heptane
2-Isobutyl-2,5-diazabicyclo[2.2.1]heptane化学式
CAS
——
化学式
C9H18N2
mdl
——
分子量
154.25
InChiKey
JIRUDBXQVKFUSL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    15.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • [EN] 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS<br/>[FR] COMPOSÉS 1H-PYRAZOLO [4,3-D]PYRIMIDINE EN TANT QU'AGONISTES DU RÉCEPTEUR 7 DE TYPE TOLL (TLR7)
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2021154661A1
    公开(公告)日:2021-08-05
    Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.
    根据公式I的化合物可作为Toll样受体7(TLR7)的激动剂。这些化合物可用于癌症治疗,特别是与抗癌免疫疗法药物联合使用,或作为疫苗佐剂。
  • ANTIBACTERIAL QUINOLINE DERIVATIVES
    申请人:Guillemont Jérôme Emile Georges
    公开号:US20100063026A1
    公开(公告)日:2010-03-11
    The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib): including any stereochemically isomeric form thereof, a pharmaceutically acceptable salt thereof, a N-oxide form thereof or a solvate thereof. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
    本发明涉及根据一般式(Ia)或式(Ib)的新型取代喹啉生物:包括其任何立体化异构体、其药学上可接受的盐、其N-氧化物形式或其溶剂合物。所述化合物用于治疗细菌感染。还声明了一种包含药学上可接受的载体和所述化合物的治疗有效量作为活性成分的组合物,所述化合物或组合物用于制造治疗细菌感染的药物以及制备所述化合物的方法。
  • USE OF SUBSTITUTED BENZODIAZEPINONES AND BENZAZEPINONES OR THE SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS
    申请人:BAYER CROPSCIENCE AG
    公开号:US20150218110A1
    公开(公告)日:2015-08-06
    The use of substituted benzodiazepinones and benzazepinones of the general formula (I) or salts thereof where the radicals in the general formula (I) correspond to the definitions given in the description, for enhancing stress tolerance in plants to abiotic stress, for strengthening plant growth and/or for increasing plant yield, and to selected processes for preparing the compounds mentioned above.
    使用通式(I)或其盐的取代苯二氮平酮和苯并氮平酮,其中通式(I)中的基团对应于描述中给出的定义,用于增强植物对非生物胁迫的耐受性,加强植物生长和/或增加植物产量,并选择上述化合物的制备过程。
  • Benzofuran Compounds
    申请人:Johansson Gary
    公开号:US20110015185A1
    公开(公告)日:2011-01-20
    The present invention relates to compounds of formula (I): wherein P, R 3 , W 1 , and W 2 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT 6 receptor-related disorders.
    本发明涉及公式(I)的化合物:其中P,R3,W1和W2如本文所述,以及包含该化合物的制药组合物,其制备过程,以及该化合物用于制备针对5-HT6受体相关疾病的药物的用途。
  • 7H-INDOLO[2,1-A][2]BENZAZEPINE-10-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF HEPATITIS C
    申请人:Bristol-Myers Squibb Company
    公开号:EP2280975B1
    公开(公告)日:2014-01-01
查看更多